SOUTH AFRICA: NGO launches countrywide monitoring of ARV rollout
2005-01-07
A new project by the South African NGO, Health Systems Trust (HST), will enable communities across the country to provide feedback on progress in the rollout of free anti-AIDS medication.
HST, based in the east-coast city of Durban, is developing a
monitoring and evaluation tool to screen communities' access to free
antiretroviral (ARV) drugs, and will also provide technical assistance in
lobbying provincial and national government.
The national treatment programme has come under fire from
activists over the slow pace of delivery and problems with the procurement of
ARVs.
In November 2003 the government committed to providing free
treatment to 53,000 patients by March 2004. This is a fraction of South Africa's
HIV positive population, thought to be over five million, and the target date
has also been moved forward a year to March 2005.
By the end of November 2004, the Joint Civil Society
Monitoring Forum estimated that only 18,500 patients were receiving the
life-prolonging drugs.
This prompted HST to launch HIV Gauge, an initiative that
gathers responses to the national ARV rollout from communities throughout the
country, to determine some of the major obstacles to the treatment plan at
community level.
By monitoring and assessing the programme in their own
districts, community members will be empowered to lobby provincial and national
government on issues around access to medication.
The HIV Gauge team has launched two pilot projects that will
form the basis for developing the monitoring tool. One project is situated in
Umlazi, a township near Durban in KwaZulu-Natal province the other is in the
poverty-stricken rural community of Sterkspruit in the Eastern Cape province.
The Umlazi project is still in the process of being set up,
but research began in Sterkspruit in July 2004. Community members, including the
local clinic committee, the HIV/AIDS provincial coordinator, the clinic sister
and an NGO operating in the area, were interviewed regularly to discover what
was hampering access to treatment.
HIV Gauge found that only five people in Sterkspruit had been
receiving ARVs, with 25 people currently on the waiting list. The main
challenges to access were lack of human resources, an inconsistent drug supply,
lack of access to information about ARVs, lack of adequate infrastructure in the
clinics and poverty.
Many people simply don't have money to pay for
transport to the clinic and nutrition, said Ashnie Padarath, advocacy and
media officer of the HST Equity Gauge.
From the information documented in the two pilot communities,
the team will create a monitoring manual for use as a tool to evaluate the
success of the ARV rollout in other communities.
The manual will measure the key components of care outlined
in the health department's treatment plan, such as: the availability and
provision of voluntary counselling and testing, prevention of mother-to-child
transmission, screening, provision and access to ARV treatment, routine
follow-up of HIV patients, treatment of opportunistic infections, adherence
monitoring and support, counselling, nutritional assistance, psychosocial
support, and community and home-based care.
While some of these services will not be offered directly by
the local clinic, the clinic should be the central point where such information
is provided, Padarath explained. Funding permitting, the manual will initially
be distributed to two communities in each province by the end of 2005. (Source:
Plusnews, 23 December 2004)
|